Table 1.
Demographic and clinical characteristics of the study groups expressed in mean ± standard deviation.
| Patients with MS (n=32) | Control group (n=29) | P | |
|---|---|---|---|
| Age (years) | 39.6±6 | 37.2±4.8 | 0.092 |
| Systolic BP (mmHg) | 147±16 | 127±13 | <0.0001 |
| Diastolic BP (mmHg) | 92±11 | 83±8 | <0.0001 |
| BMI (kg/m2) | 33.03±5.35 | 23.89±3.01 | <0.0001 |
| Wc (cm) | 112.3±11.2 | 91.2±4.7 | <0.0001 |
| FPG (mg/dl) | 138.7±57.6 | 81.3±10.3 | <0.0001 |
| PPPG (mg/dl) | 204.2±90.4 | 111.1±15.9 | <0.0001 |
| Insulin | 12.1±7.13 | 6.01±2.72 | <0.0001 |
| T-Chol (mg/dl) | 224.4±48.1 | 169.1±36.4 | <0.0001 |
| TG (mg/dl) | 269.6±126.8 | 101.4±50.1 | <0.0001 |
| LDL-C (mg/dl) | 125.4±43.5 | 107.5±27.8 | 0.058 |
| HDL-C (mg/dl) | 40.5±6.4 | 43.2±11.9 | 0.262 |
| hs-CRP | 3.74±2.84 | 0.85±0.76 | <0.0001 |
| CIMT (mm) | 0.76±0.11 | 0.53±0.06 | <0.0001 |
| TT (ng/ml) | 4.8±1.2 | 6.4±1.6 | <0.0001 |
MS – metabolic syndrome; NS – non-significant; BP – blood pressure; BMI – body mass index; Wc – weight circumference; FPG – fasting plasma glucose; PPPG – postprandial plasma glucose; T-chol – total cholesterol; TG – triglyceride; LDL-C – low density lipoprotein cholesterol; HDL-C – high density lipoprotein cholesterol; hs-CRP – high sensitive C reactive protein; CIMT – carotid intima media thickness; TT – total testosterone.